|
IDE expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.056200E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.423200E-01 |
| Normal-vs-Stage2 |
5.710400E-01 |
| Normal-vs-Stage3 |
4.243800E-02 |
| Normal-vs-Stage4 |
2.704600E-01 |
| Stage1-vs-Stage2 |
9.348800E-01 |
| Stage1-vs-Stage3 |
8.470400E-02 |
| Stage1-vs-Stage4 |
5.341600E-01 |
| Stage2-vs-Stage3 |
2.703800E-01 |
| Stage2-vs-Stage4 |
6.896200E-01 |
| Stage3-vs-Stage4 |
5.242600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.925450E-01 |
| Normal-vs-AfricanAmerican |
6.957600E-01 |
| Normal-vs-Asian |
1.076440E-01 |
| Caucasian-vs-AfricanAmerican |
2.548400E-01 |
| Caucasian-vs-Asian |
4.817400E-01 |
| AfricanAmerican-vs-Asian |
1.204020E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.999800E-02 |
| Normal-vs-Female |
4.170800E-01 |
| Male-vs-Female |
7.763600E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.247000E-01 |
| Normal-vs-Age(41-60Yrs) |
6.086500E-02 |
| Normal-vs-Age(61-80Yrs) |
5.213600E-01 |
| Normal-vs-Age(81-100Yrs) |
2.856400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.163500E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.173000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.894000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.730190E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.917200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.554000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.570000E-01 |
| Classical-VS-Follicular |
2.050200E-01 |
| Classical-VS-Other |
6.326200E-02 |
| Classical-VS-Normal |
6.179600E-01 |
| Tall-VS-Follicular |
7.667800E-01 |
| Tall-VS-Other |
1.284030E-01 |
| Tall-VS-Normal |
1.305180E-01 |
| Follicular-VS-Other |
1.922190E-01 |
| Follicular-VS-Normal |
1.728990E-01 |
| Other-VS-Normal |
1.518040E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.103020E-01 |
| Normal-vs-N1 |
4.648000E-02 |
| N0-vs-N1 |
3.897000E-01 |
|
|
